EA202091803A1 - Производные триазолопиримидина для применения в качестве ингибиторов грелин-о-ацилтрансферазы (goat) - Google Patents
Производные триазолопиримидина для применения в качестве ингибиторов грелин-о-ацилтрансферазы (goat)Info
- Publication number
- EA202091803A1 EA202091803A1 EA202091803A EA202091803A EA202091803A1 EA 202091803 A1 EA202091803 A1 EA 202091803A1 EA 202091803 A EA202091803 A EA 202091803A EA 202091803 A EA202091803 A EA 202091803A EA 202091803 A1 EA202091803 A1 EA 202091803A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- acyltransferase
- goat
- grelin
- inhibitors
- triazolopyrimidine derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Abstract
Настоящее изобретение относится к соединениям общей формулы Iгде группы R1 и R2 имеют значения, указанные в п.1, которые обладают ценными фармакологическими свойствами, в частности связываются с грелин-O-ацилтрансферазой (GOAT) и модулируют ее активность. Соединения являются пригодными для лечения и предотвращения заболеваний, на которые может влиять этот рецептор, таких как метаболические заболевания, в частности ожирение.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18154831 | 2018-02-02 | ||
PCT/EP2019/051994 WO2019149660A1 (en) | 2018-02-02 | 2019-01-28 | Triazolopyrimidine derivatives for use as ghrelin o-acyl transferase (goat) inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
EA202091803A1 true EA202091803A1 (ru) | 2020-12-16 |
Family
ID=61157054
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA202091803A EA202091803A1 (ru) | 2018-02-02 | 2019-01-28 | Производные триазолопиримидина для применения в качестве ингибиторов грелин-о-ацилтрансферазы (goat) |
Country Status (21)
Country | Link |
---|---|
US (1) | US11583532B2 (ru) |
EP (1) | EP3746443B1 (ru) |
JP (1) | JP7083397B2 (ru) |
KR (1) | KR20200118125A (ru) |
CN (1) | CN111683951B (ru) |
AU (1) | AU2019215710A1 (ru) |
BR (1) | BR112020014436A2 (ru) |
CA (1) | CA3087925A1 (ru) |
CL (1) | CL2020001909A1 (ru) |
CO (1) | CO2020009177A2 (ru) |
CR (1) | CR20200329A (ru) |
EA (1) | EA202091803A1 (ru) |
EC (1) | ECSP20050797A (ru) |
IL (1) | IL276145A (ru) |
JO (1) | JOP20200187A1 (ru) |
MA (1) | MA51774A (ru) |
MX (1) | MX2020007994A (ru) |
PE (1) | PE20210658A1 (ru) |
PH (1) | PH12020551170A1 (ru) |
SG (1) | SG11202006302TA (ru) |
WO (1) | WO2019149660A1 (ru) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3033058A1 (en) | 2016-08-05 | 2018-02-08 | Boehringer Ingelheim International Gmbh | Oxadiazolopyridine derivates for use as ghrelin o-acyl transferase (goat) inhibitors |
KR20200118125A (ko) | 2018-02-02 | 2020-10-14 | 베링거 인겔하임 인터내셔날 게엠베하 | 그렐린 o-아실 트랜스퍼라제(goat) 억제제로 사용하기 위한 트리아졸로피리미딘 유도체 |
AU2019215707A1 (en) | 2018-02-02 | 2020-07-09 | Boehringer Ingelheim International Gmbh | Benzyl-, (pyridin-3-yl)methyl- or (pyridin-4-yl)methyl-substituted oxadiazolopyridine derivatives as ghrelin O-acyl transferase (GOAT) inhibitors |
WO2021195425A1 (en) * | 2020-03-26 | 2021-09-30 | Sinopia Biosciences, Inc. | Isotopically-labelled trapidil derivatives |
EP4146344A1 (en) | 2020-05-04 | 2023-03-15 | Volastra Therapeutics, Inc. | Imino sulfanone inhibitors of enpp1 |
WO2021233882A1 (en) | 2020-05-22 | 2021-11-25 | Boehringer Ingelheim International Gmbh | Process for manufacturing alkyl 7-amino-5-methyl-[1,2,5]oxadiazolo[3,4-b]pyridine-carboxylate |
TW202214640A (zh) * | 2020-06-16 | 2022-04-16 | 美商佛拉斯托醫療公司 | Enpp1之雜環抑制劑 |
CN115073363B (zh) * | 2022-06-16 | 2024-01-26 | 宁波申泰生物科技有限公司 | 一种5-氟-2-甲氧基烟醛及其制备方法 |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3338292A1 (de) * | 1983-10-21 | 1985-05-02 | Basf Ag, 6700 Ludwigshafen | 7-amino-azolo(1,5-a)-pyrimidine und diese enthaltende fungizide |
JP2002249492A (ja) | 2000-12-22 | 2002-09-06 | Nippon Bayer Agrochem Co Ltd | トリアゾロピリミジン類 |
WO2004082383A1 (en) | 2003-03-17 | 2004-09-30 | Basf Aktiengesellschaft | Use of triazolopyrimidines for combating nematode diseases of plants |
CN101163404A (zh) * | 2005-04-25 | 2008-04-16 | 巴斯福股份公司 | 5-烷基-6-苯基烷基-7-氨基唑并嘧啶的用途、新的唑并嘧啶、其制备方法以及包含它们的组合物 |
AU2008216265B2 (en) | 2007-02-15 | 2014-04-03 | Indiana University Research And Technology Corporation | Glucagon/GLP-1 receptor co-agonists |
HUE059861T2 (hu) | 2007-04-11 | 2023-01-28 | Canbas Co Ltd | N-Szubsztituált 2,5-dioxo-azolin vegyületek a rák kezelésében való felhasználásra |
CN101720327A (zh) | 2007-04-30 | 2010-06-02 | 雅培制药有限公司 | 二酰甘油o-酰基转移酶1型酶的抑制剂 |
EP2152672A1 (en) | 2007-05-24 | 2010-02-17 | Bayer Schering Pharma Aktiengesellschaft | Novel sulphoximine-substituted quinazoline and quinazoline derivatives as kinase inhibitors |
JP5385266B2 (ja) | 2007-06-15 | 2014-01-08 | ジーランド ファーマ アクティーゼルスカブ | グルカゴン類似体 |
FR2934058B1 (fr) | 2008-07-15 | 2010-09-24 | Centre Nat Rech Scient | Dispositif de projection interferometrique a trois ouvertures pour produire une tache constituee de structures fines |
FR2933989B1 (fr) | 2008-07-16 | 2013-03-08 | Commissariat Energie Atomique | Procede de purification de microorganismes presents dans des echantillons liquides |
FR2933975B1 (fr) | 2008-07-17 | 2011-02-18 | Servier Lab | Nouveau procede de preparation de benzocyclobutenes fonctionnalises,et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable. |
MX2011006320A (es) | 2008-12-15 | 2011-09-22 | Zealand Pharma As | Analogos de glucagon. |
UA104605C2 (ru) | 2008-12-15 | 2014-02-25 | Зіленд Фарма А/С | Аналоги глюкагона |
DK2370462T3 (da) | 2008-12-15 | 2014-09-08 | Zealand Pharma As | Glucagon-analoger |
ES2477880T3 (es) | 2008-12-15 | 2014-07-18 | Zealand Pharma A/S | Análogos del glucagón |
DK2454282T3 (en) | 2009-07-13 | 2015-05-04 | Zealand Pharma As | acetylated glucagonanaloger |
US20110078154A1 (en) | 2009-09-28 | 2011-03-31 | Accenture Global Services Gmbh | Recruitment screening tool |
WO2011114148A1 (en) | 2010-03-17 | 2011-09-22 | Astrazeneca Ab | 4h- [1, 2, 4] triazolo [5, 1 -b] pyrimidin-7 -one derivatives as ccr2b receptor antagonists |
UY33462A (es) | 2010-06-23 | 2012-01-31 | Zealand Pharma As | Analogos de glucagon |
WO2011160633A1 (en) | 2010-06-24 | 2011-12-29 | Zealand Pharma A/S | Glucagon analogues |
PE20142113A1 (es) | 2011-12-23 | 2014-12-03 | Zealand Pharma As | Analogos de glucagon |
CA2864990C (en) | 2012-02-24 | 2021-03-02 | Nobuyuki Takakura | Benzofuran and benzothiophene compounds for the inhibition of ghrelin o-acyltranferase (goat) |
ES2784223T3 (es) | 2012-06-20 | 2020-09-23 | Univ Virginia Patent Foundation | Composiciones y procedimientos para regular la homeostasis de glucosa y la acción de insulina |
TWI608013B (zh) | 2012-09-17 | 2017-12-11 | 西蘭製藥公司 | 升糖素類似物 |
UA118034C2 (uk) | 2013-11-14 | 2018-11-12 | Елі Ліллі Енд Компані | Заміщений піперидилетилпіримідин як інгібітор грелін-o-ацилтрансферази |
EP3193939A4 (en) | 2014-09-17 | 2018-10-24 | The Regents of The University of California | Small lipopeptidomimetic inhibitors of ghrelin o-acyl transferase |
US10131642B1 (en) | 2015-01-30 | 2018-11-20 | Boehringer Ingelheim International Gmbh | Aldosterone synthase inhibitors |
AR104673A1 (es) | 2015-04-15 | 2017-08-09 | Lilly Co Eli | Inhibidores de grelina o-aciltransferasa |
AR104672A1 (es) | 2015-04-15 | 2017-08-09 | Lilly Co Eli | Inhibidores de grelina o-aciltransferasa |
AU2016341429B2 (en) | 2015-10-22 | 2023-09-21 | Cavion, Inc. | Methods for treating Angelman Syndrome and related disorders |
CA3033058A1 (en) | 2016-08-05 | 2018-02-08 | Boehringer Ingelheim International Gmbh | Oxadiazolopyridine derivates for use as ghrelin o-acyl transferase (goat) inhibitors |
EP3504185B1 (en) | 2016-08-29 | 2021-11-24 | Merck Sharp & Dohme Corp. | Novel substituted n'-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase (ido) inhibitors |
KR20200118125A (ko) * | 2018-02-02 | 2020-10-14 | 베링거 인겔하임 인터내셔날 게엠베하 | 그렐린 o-아실 트랜스퍼라제(goat) 억제제로 사용하기 위한 트리아졸로피리미딘 유도체 |
CR20200331A (es) | 2018-02-02 | 2020-09-03 | Boehringer Ingelheim Int | Derivados de oxadiazolopirisdina sustituidos con heterociclilo para usar como inhibidores de ghrelin o-aciltrasferasa (goat) |
US11136337B2 (en) | 2018-02-02 | 2021-10-05 | Boehringer Ingelheim International Gmbh | Pyrazole- and indazole-substituted oxadiazolopyridine derivatives for use as ghrelin O-acyl transferase (GOAT) inhibitors |
AU2019215707A1 (en) | 2018-02-02 | 2020-07-09 | Boehringer Ingelheim International Gmbh | Benzyl-, (pyridin-3-yl)methyl- or (pyridin-4-yl)methyl-substituted oxadiazolopyridine derivatives as ghrelin O-acyl transferase (GOAT) inhibitors |
-
2019
- 2019-01-28 KR KR1020207025419A patent/KR20200118125A/ko unknown
- 2019-01-28 WO PCT/EP2019/051994 patent/WO2019149660A1/en unknown
- 2019-01-28 EA EA202091803A patent/EA202091803A1/ru unknown
- 2019-01-28 AU AU2019215710A patent/AU2019215710A1/en not_active Abandoned
- 2019-01-28 JP JP2020541900A patent/JP7083397B2/ja active Active
- 2019-01-28 CA CA3087925A patent/CA3087925A1/en not_active Abandoned
- 2019-01-28 MA MA051774A patent/MA51774A/fr unknown
- 2019-01-28 CR CR20200329A patent/CR20200329A/es unknown
- 2019-01-28 MX MX2020007994A patent/MX2020007994A/es unknown
- 2019-01-28 CN CN201980010417.7A patent/CN111683951B/zh active Active
- 2019-01-28 BR BR112020014436-3A patent/BR112020014436A2/pt not_active Application Discontinuation
- 2019-01-28 JO JOP/2020/0187A patent/JOP20200187A1/ar unknown
- 2019-01-28 SG SG11202006302TA patent/SG11202006302TA/en unknown
- 2019-01-28 US US16/966,493 patent/US11583532B2/en active Active
- 2019-01-28 EP EP19702247.8A patent/EP3746443B1/en active Active
- 2019-01-28 PE PE2020001164A patent/PE20210658A1/es unknown
-
2020
- 2020-07-19 IL IL276145A patent/IL276145A/en unknown
- 2020-07-21 CL CL2020001909A patent/CL2020001909A1/es unknown
- 2020-07-24 CO CONC2020/0009177A patent/CO2020009177A2/es unknown
- 2020-07-31 PH PH12020551170A patent/PH12020551170A1/en unknown
- 2020-08-24 EC ECSENADI202050797A patent/ECSP20050797A/es unknown
Also Published As
Publication number | Publication date |
---|---|
SG11202006302TA (en) | 2020-07-29 |
WO2019149660A1 (en) | 2019-08-08 |
IL276145A (en) | 2020-09-30 |
EP3746443A1 (en) | 2020-12-09 |
CR20200329A (es) | 2020-09-04 |
ECSP20050797A (es) | 2020-09-30 |
CN111683951B (zh) | 2023-10-13 |
AU2019215710A1 (en) | 2020-07-23 |
CA3087925A1 (en) | 2019-08-08 |
PH12020551170A1 (en) | 2021-05-31 |
CL2020001909A1 (es) | 2020-10-30 |
MX2020007994A (es) | 2020-09-09 |
BR112020014436A2 (pt) | 2020-12-01 |
US11583532B2 (en) | 2023-02-21 |
US20210038603A1 (en) | 2021-02-11 |
KR20200118125A (ko) | 2020-10-14 |
JOP20200187A1 (ar) | 2020-07-29 |
JP2021512115A (ja) | 2021-05-13 |
CO2020009177A2 (es) | 2020-07-31 |
JP7083397B2 (ja) | 2022-06-10 |
EP3746443B1 (en) | 2022-07-06 |
PE20210658A1 (es) | 2021-03-31 |
CN111683951A (zh) | 2020-09-18 |
MA51774A (fr) | 2021-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA202091803A1 (ru) | Производные триазолопиримидина для применения в качестве ингибиторов грелин-о-ацилтрансферазы (goat) | |
EA201990418A1 (ru) | Производные оксадиазолопиридина для применения в качестве ингибиторов грелин-о-ацилтрасферазы (goat) | |
EA202092896A1 (ru) | Гетероциклические и гетероарильные соединения для лечения болезни гентингтона | |
EA202091804A1 (ru) | Гетероциклил-замещенные оксадиазолопиридиновые производные для применения в качестве ингибиторов грелин-о-ацилтрансферазы (goat) | |
EA202091805A1 (ru) | Бензил-, (пиридин-3-ил)метил- или (пиридин-4-ил)метил-замещенные оксадиазолопиридиновые производные в качестве ингибиторов грелин-о-ацилтрансферазы (goat) | |
EA201992253A1 (ru) | Новые гетероциклические производные, применимые в качестве ингибиторов shp2 | |
EA202091508A1 (ru) | 6-азаиндольные соединения | |
PH12018500177A1 (en) | Compositions useful for treating disorders related to kit and pdfgr | |
EA201890338A1 (ru) | Оксадиазольные производные, пригодные в качестве ингибиторов hdac | |
EA201401053A1 (ru) | Новые производные инданилоксидигидробензофуранилуксусной кислоты и их применение в качестве агонистов рецептора gpr40 | |
EA201891974A1 (ru) | Ингибиторы связывания белка wdr5 с белками | |
EA202090256A1 (ru) | 5-членные и бициклические гетероциклические амиды в качестве ингибиторов rock | |
EA201592033A1 (ru) | 3-(2-АМИНОПИРИМИДИН-4-ИЛ)-5-(3-ГИДРОКСИПРОПИНИЛ)-1H-ПИРРОЛО[2,3-c]ПИРИДИНОВЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ NIK ДЛЯ ЛЕЧЕНИЯ РАКА | |
EA201070039A1 (ru) | Спироциклы в качестве ингибиторов 11-бета гидроксилстероиддегидрогеназы типа 1 | |
EA201600113A1 (ru) | Новые производные азабензимидазола | |
EA200970818A1 (ru) | Гетероциклические соединения, содержащие их композиции и способы их применения | |
EA201692260A1 (ru) | Соединения 1,3,4-тиадиазола и их применение в лечении рака | |
EA202090414A1 (ru) | Соединения и их применение | |
EA202190464A1 (ru) | Замещенные бензимидазолы в качестве ингибиторов pad4 | |
EA202191478A1 (ru) | Гетероароматические соединения в качестве ингибиторов ванина | |
EA201791829A1 (ru) | Амидные соединения в качестве агонистов рецептора 5-ht | |
EA201790830A1 (ru) | Ингибиторы альдостеронсинтазы | |
EA201790253A1 (ru) | Ингибиторы альдостеронсинтазы | |
EA202092446A1 (ru) | ТИАЗОЛ- ИЛИ ТИАДИАЗОЛЗАМЕЩЕННЫЕ АРИЛЬНЫЕ И ГЕТЕРОАРИЛЬНЫЕ ПРОИЗВОДНЫЕ КАК ИНГИБИТОРЫ Vps34 | |
EA201990196A1 (ru) | Пиридопиримидиноновые ингибиторы cdk2/4/6 |